Evidence map›Paper›PMID 39439819›Full record

ReviewJournal of the Royal Society of New Zealand2022

Monitoring airborne pollen in New Zealand.

Rewi M Newnham

Abstract readReview
In one paragraph

Review in Journal of the Royal Society of New Zealand, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Rewi M NewnhamSchhol of Geography, Environment & Earth Sciences, Victoria University of Wellington, Wellington, New Zealand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Against a backdrop of increasing pollen allergy prevalence, this paper reviews the current state of knowledge of allergenic pollen loading in New Zealand. An unavoidable conclusion is that relevant available datasets are fragmentary, incomplete and out-of-date, with the last nationwide survey conducted >30 years ago. In contrast, many other developed regions continue to provide routine, standardised pollen reporting and forecasting to assist with the management and treatment of seasonal allergic rhinitis and related diseases, which affect a large proportion of the population. The data also inform wider research including investigating allergic rhinitis co-association with other health issues and monitoring and projecting the impacts of climate change on pollen production and dispersal; fundamental biological processes that underpin most life on Earth. New Zealand is lagging well behind other regions in realising these benefits by failing to implement a programme of routine aeroallergen monitoring at major population centres. The data generated would also help to answer some pressing questions in relation to respiratory disorder in New Zealand and in particular whether the timing and severity of key pollen allergens are changing and new sources are establishing as a result of climate change.

Indexed as

allergic rhinitisasthmaclimate changeHayfeverNew Zealandpollen

Identifiers

PMID39439819
PMCPMC11486117

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.